| TIGIT as a therapeutic target of HPV-positive head and neck squamous cell carcinomas X Le, M Dang, VL Hegde, B Jiang, R Slay, W Xiao, K Akagi, J Fresquez, ... medRxiv, 2021.12. 02.21266776, 2021 | 1 | 2021 |
| 754 TIGIT-PVR is a key immune checkpoint and therapeutic target in HPV-positive head and neck squamous cell carcinomas X Le, M Dang, V Hegde, B Jiang, R Slay, W Xiao, K Akagi, J Fresquez, ... Journal for ImmunoTherapy of Cancer 9 (Suppl 2), A788-A788, 2021 | | 2021 |
